HTC
RDHL

Haverford Trust Company’s Redhill Biopharma RDHL Stock Holding History

Haverford Trust Company’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$5K – 338
2022
Q3 		$5K Buy
+10
New +$8.71K ﹤0.01% 334

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Haverford Trust Company's RDHL Position: Q4 2022 in Review

Haverford Trust Company sold out of Redhill Biopharma (RDHL) in Q4 2022, closing a stake of 10 shares — an estimated $5K sold.

Haverford Trust Company first reported a position in RDHL in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 37 funds tracked by Wall St. Rank hold RDHL as of Q4 2022.

  • Haverford Trust Company reported no remaining Redhill Biopharma position as of Q4 2022 after selling out during the quarter.
  • Haverford Trust Company sold 10 Redhill Biopharma shares in Q4 2022, an estimated $5K.
  • Haverford Trust Company first reported a position in Redhill Biopharma in Q3 2022 and held it in 1 quarter.
  • Haverford Trust Company's Redhill Biopharma position peaked at $5K in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2022.

Based on Haverford Trust Company's 13F filing for Q4 2022, filed 13 Feb 2023.